What is the main business of Bionexen?

The main business activity of Bionexen focuses on wholesale of other machinery and equipment.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 16, 2017.

Where is the headquarters located?

The headquarters is located at: ul. Komfortowa 1, 02-995 Warszawa.

Who is on the management board?

The management board includes Mariusz Trojanowski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $16,938 in 2024, which is an increase of 9012981.3% compared to 2023.

Yes, the company recorded a net profit of $3,839 in 2024.

Bionexensp. z o.o.

Wholesale of other machinery and equipment

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2017-11-16

Share capital

5,000.00 PLN

Activity description

Bionexen designs and supplies single-use systems, including 2D and 3D bags and ready-to-use solutions for laboratories and biotechnological production. The company supports the use of these systems and designs and builds laboratory and production areas for biotechnology and pharmaceuticals.

Registered address

ul. Komfortowa 1/1, 02-995 Warszawa, Poland

Website

bionexen.com

Electronic delivery address

AE:PL-46459-45964-SDUDR-21

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 10 days late).

202508/07/2026
202415/07/2025
202304/07/2024
202221/06/2023
202125/07/2022
202014/09/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 211.59kMedianUSD 889.63kAverageUSD 5.09m

Net profit

This companyUSD 6.32kMedianUSD 23.80kAverageUSD 228.16k

Operating costs

This companyUSD 202.54kMedianUSD 810.05kAverageUSD 4.73m

Assets

This companyUSD 105.90kMedianUSD 556.95kAverageUSD 3.74m

Industry

Authorized Representatives

Krzysztof Łupiński – Vice President of the Management Board

Mariusz Trojanowski – President of the Management Board

Manner of representation

The making of declarations on behalf of the company requires the joint action of two members of the management board, or of one member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Krzysztof Łupińskiage 53	50	$675.31	50%
Mariusz Trojanowskiage 51	50	$675.31	50%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2017-11-23.

mBank
51 1140 1065 0000 2661 8700 1002
mBank
78 1140 1065 0000 2661 8700 1001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 26, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Stołecznego Warszawy

Competitors

Name	Revenue	Website
Agrosystemysp. z o.o.	$582,639.29	agrosystemy.pl
Polygensp. z o.o.	$575,907.38	polygen.pl
PharmenaS.A.	$541,436.46	pharmena.eu
Biocomsp. z o.o.	$433,929.05	biocom.net.pl
Borensp. z o.o.	$316,178.07	boren.pl
Ekob-Tbasp. z o.o.	$257,658.44	ekobtba.pl
Magbexsp. z o.o.	$256,888.17	magbex.pl
Bionaftsp. z o.o.	$219,078.76	bionaft.pl
Bioingsp. z o.o.	$121,417.17	bioing.pl
Pharmbiopolsp. z o.o.	$99,211.10	pharmbiopol.com